.
MergerLinks Header Logo

New Deal


Announced

Completed

Fidelity Management & Research Company led a $100m Series B round in Galvanize Therapeutics.

Synopsis

Fidelity Management & Research Company, a privately-owned investment manager, led a $100m Series B round in Galvanize Therapeutics, a commercial-stage biomedical platform company operating at the convergence of engineering, biology and healthcare delivery, with participation from Intuitive Surgical, ATP, and Gilmartin Capital. "We are energized by this vote of confidence from our investors in our technology platform and team as we seek to bring transformative electrosurgical therapies to patients worldwide," Jonathan Waldstreicher, Galvanize Therapeutics Founder and CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US